161 related articles for article (PubMed ID: 26112867)
41. Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients.
Coll-de-Tuero G; Saez M; Roca-Saumell C; Rodriguez-Poncelas A; Franco P; Dalfó A; Calvó-Perxas L; Pose-Reino A; Bayó-Llibre J
Am J Hypertens; 2012 Dec; 25(12):1256-63. PubMed ID: 22914254
[TBL] [Abstract][Full Text] [Related]
42. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
43. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
[TBL] [Abstract][Full Text] [Related]
44. The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years.
Aissopou EK; Papathanassiou M; Nasothimiou EG; Konstantonis GD; Tentolouris N; Theodossiadis PG; Papaioannou TG; Sfikakis PP; Protogerou AD
J Hypertens; 2015 Nov; 33(11):2303-9. PubMed ID: 26335430
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
46. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
47. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
[TBL] [Abstract][Full Text] [Related]
48. Retinal arteriole-to-venule ratio changes and target organ disease evolution in newly diagnosed hypertensive patients at 1-year follow-up.
Coll-de-Tuero G; González-Vázquez S; Rodríguez-Poncelas A; Barceló MA; Barrot-de-la Puente J; Penedo MG; Pose-Reino A; Pena-Seijo M; Saez M
J Am Soc Hypertens; 2014 Feb; 8(2):83-93. PubMed ID: 24239162
[TBL] [Abstract][Full Text] [Related]
49. The relationship between microalbuminuria, left ventricular hypertrophy, retinopathy, and sex hormone status in newly diagnosed hypertensive women.
Apikoglu M; Bulucu F; Demirbas S; Ay SA; Karaman M; Altun B; Balta S; Gokce G; Demirkol S; Yaman H; Saglam K
Clin Exp Hypertens; 2013; 35(5):325-9. PubMed ID: 22950595
[TBL] [Abstract][Full Text] [Related]
50. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study.
Sairenchi T; Iso H; Yamagishi K; Irie F; Okubo Y; Gunji J; Muto T; Ota H
Circulation; 2011 Dec; 124(23):2502-11. PubMed ID: 22064594
[TBL] [Abstract][Full Text] [Related]
51. Target organ damage in hypertensive patients: correlation between retinal arteriovenular ratio and left ventricular geometric patterns.
Meazza R; Scardino C; Grosso Di Palma L; Perrucci GL; Gallazzi E; Cattaneo M; Villarini A; Magrini F
J Hum Hypertens; 2014 Apr; 28(4):274-8. PubMed ID: 23903196
[TBL] [Abstract][Full Text] [Related]
52. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Oikarinen L; Nieminen MS; Viitasalo M; Toivonen L; Jern S; Dahlöf B; Devereux RB; Okin PM;
Hypertension; 2004 May; 43(5):1029-34. PubMed ID: 15037560
[TBL] [Abstract][Full Text] [Related]
53. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
54. [The prognostic characteristics of hypertensive left ventricular hypertrophy in a rural population].
Chen D; Wu K; Xie L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Feb; 16(1):29-34. PubMed ID: 7954964
[TBL] [Abstract][Full Text] [Related]
55. Target Organ Damage and Target Systolic Blood Pressure in Clinical Practice: The Campania Salute Network.
D'Amato A; Mancusi C; Losi MA; Izzo R; Arnone MI; Canciello G; Senese S; De Luca N; de Simone G; Trimarco B
Am J Hypertens; 2018 May; 31(6):658-664. PubMed ID: 29566163
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
Salles GF; Deccache W; Cardoso CR
J Hum Hypertens; 2005 Mar; 19(3):241-9. PubMed ID: 15660120
[TBL] [Abstract][Full Text] [Related]
57. The value of ABPM and subclinical target organ damage parameters in diagnosis of resistant hypertension.
Poveda García MI; Del Pino Y Pino MD; Alarcón Rodriguez R; Rodelo-Haad C; Parrón Carreño T
Nefrologia (Engl Ed); 2019; 39(1):67-72. PubMed ID: 30001849
[TBL] [Abstract][Full Text] [Related]
58. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
59. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
Cerasola G; Nardi E; Mulè G; Palermo A; Cusimano P; Guarneri M; Arsena R; Giammarresi G; Carola Foraci A; Cottone S
Nephrology (Carlton); 2010 Mar; 15(2):203-10. PubMed ID: 20470280
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of Target Organ Damage in Chinese Hypertensive Children and Adolescents.
Yang L; Yang L; Zhang Y; Xi B
Front Pediatr; 2018; 6():333. PubMed ID: 30525012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
